CDC25A mRNA levels significantly correlate with Ki-67 expression in human glioma samples

Journal of Neuro-Oncology

Volumn 100, Issue 1, 2010, Pages 43-49

  Yamashita, Yoji ^a,b   Kasugai, Isao ^a   Sato, Masami ^a   Tanuma, Nobuhiro ^a   Sato, Ikuro ^a   Nomura, Miyuki ^a   Yamashita, Katsumi ^c   Sonoda, Yukihiko ^d   Kumabe, Toshihiro ^d   Tominaga, Teiji ^d   Katakura, Ryuichi ^b   Shima, Hiroshi ^a  

^a MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Miyagi Cancer Center   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CDC25A; Glioma; Ki 67; Protein phosphatase

Indexed keywords

CDC25A PHOSPHATASE; CDC25B PHOSPHATASE; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC LINKAGE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; MALE; PROTEIN DEPLETION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BENZOQUINONES; BRAIN NEOPLASMS; CASPASE 3; CASPASE 7; CDC25 PHOSPHATASES; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ETHYLAMINES; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NITRO COMPOUNDS; RNA, MESSENGER; RNA, SMALL INTERFERING; STATISTICS AS TOPIC; THIAZOLES; TIME FACTORS; TRANSFECTION; UP-REGULATION; YOUNG ADULT;

EID: 79952191211     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0147-3     Document Type: Article

References (13)

1. Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445-1453 (Pubitemid 47339290)
2. Sathornssumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN (2007) Molecularly targeted therapy for malignant glioma. Cancer 110:13-24
3. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812
4. Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK, Dobra A, Dressman HK, Bigner DD, Nevins JR, West M (2005) Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 65:4051-4058 (Pubitemid 40775641)
5. Faria MH, Gonçalves BP, do Patrocínio RM, de Moraes-Filho MO, Rabenhorst SH (2006) Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status. Neuropathology 26:519-527 (Pubitemid 44800287)
6. Johannessen AL, Torp SH (2006) The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas. Pathol Oncol Res 12:143-147 (Pubitemid 44719640)
7. Boutros R, Dozier C, Ducommun B (2006) The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 18:185-191 (Pubitemid 43375887)
8. Boutros R, Lobjois V, Ducommun B (2007) CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 7:495-507
9. Kiyokawa H, Ray D (2008) In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets. Anticancer Agents Med Chem 8:826-832
10. Lazo JS, Wipf P (2008) Is Cdc25 a druggable target? Anticancer Agents Med Chem 8:837-842
11. Brezak MC, Quaranta M, Mondésert O, Galcera MO, Lavergne O, Alby F, Cazales M, Baldin V, Thurieau C, Harnett J, Lanco C, Kasprzyk PG, Prevost GP, Ducommun B (2004) A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res 64:3320-3325 (Pubitemid 38581439)
12. Brezak MC, Quaranta M, Contour-Galcera MO, Lavergne O, Mondesert O, Auvray P, Kasprzyk PG, Prevost GP, Ducommun B (2005) Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases. Mol Cancer Ther 4:1378-1387
13. Nakabayashi H, Hara M, ShimizuK(2006) Prognostic significance of CDC25B expression in gliomas. J Clin Pathol 59:725-728